全文获取类型
收费全文 | 2608篇 |
免费 | 197篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 35篇 |
妇产科学 | 121篇 |
基础医学 | 261篇 |
口腔科学 | 53篇 |
临床医学 | 316篇 |
内科学 | 563篇 |
皮肤病学 | 116篇 |
神经病学 | 109篇 |
特种医学 | 96篇 |
外科学 | 407篇 |
综合类 | 79篇 |
一般理论 | 2篇 |
预防医学 | 255篇 |
眼科学 | 15篇 |
药学 | 234篇 |
中国医学 | 1篇 |
肿瘤学 | 140篇 |
出版年
2021年 | 35篇 |
2020年 | 17篇 |
2019年 | 27篇 |
2018年 | 29篇 |
2017年 | 21篇 |
2016年 | 34篇 |
2015年 | 34篇 |
2014年 | 57篇 |
2013年 | 94篇 |
2012年 | 109篇 |
2011年 | 115篇 |
2010年 | 54篇 |
2009年 | 64篇 |
2008年 | 110篇 |
2007年 | 124篇 |
2006年 | 139篇 |
2005年 | 124篇 |
2004年 | 103篇 |
2003年 | 79篇 |
2002年 | 96篇 |
2001年 | 84篇 |
2000年 | 96篇 |
1999年 | 68篇 |
1998年 | 29篇 |
1997年 | 34篇 |
1996年 | 45篇 |
1995年 | 37篇 |
1994年 | 26篇 |
1993年 | 27篇 |
1992年 | 47篇 |
1991年 | 65篇 |
1990年 | 83篇 |
1989年 | 64篇 |
1988年 | 65篇 |
1987年 | 54篇 |
1986年 | 59篇 |
1985年 | 46篇 |
1984年 | 30篇 |
1983年 | 34篇 |
1981年 | 26篇 |
1980年 | 21篇 |
1979年 | 24篇 |
1978年 | 19篇 |
1977年 | 17篇 |
1976年 | 23篇 |
1974年 | 16篇 |
1973年 | 17篇 |
1972年 | 18篇 |
1971年 | 18篇 |
1969年 | 17篇 |
排序方式: 共有2814条查询结果,搜索用时 15 毫秒
41.
Expression of AML1-ETO in human myelomonocytic cells selectively inhibits granulocytic differentiation and promotes their self-renewal. 总被引:1,自引:0,他引:1
A Tonks A J Tonks L Pearn L Pearce T Hoy S Couzens J Fisher A K Burnett R L Darley 《Leukemia》2004,18(7):1238-1245
The t(8;21) translocation is one of the most frequent translocations in acute myeloid leukaemia (AML), giving rise to the AML1-ETO fusion protein (or RUNX1-CBF2T1). This abnormality is associated with myelocytic leukaemia with dysplastic granulopoiesis. Here, we demonstrate that when expressed in a normal human (CD34(+)) progenitor population, AML1-ETO selectively inhibits granulocyte colony formation but not monocyte colony formation. In bulk liquid culture, we found that though AML1-ETO transiently inhibited the proliferation of CD34(+) cells, it promoted long-term growth of myeloid cells for more than 80 days, suggesting that differentiation was inhibited. In support of this, cultures expressing AML1-ETO demonstrated enhanced retention of colony-forming capacity. Phenotypic examination of AML1-ETO cultures revealed a defect in granulocytic differentiation in terms of retention of CD34(+) cells within the culture and delayed CD11b upregulation. Morphologically, granulocyte terminal differentiation in AML1-ETO-expressing cells was inhibited by 83+/-5%, giving rise to a build-up of early to intermediate granulocytes that exhibited a number of morphological features associated with t(8;21) leukaemias. In contrast, AML1-ETO had little or no effect on monocytic differentiation. Taken together, these results suggest that expression of AML1-ETO selectively inhibits the differentiation of granulocytic cells and promoted extensive self-renewal, supporting a causal role for t(8;21) translocations in leukaemogenesis. 相似文献
42.
43.
Darrell J Gaskin Kevin P Weinfurt Liana D Castel Venita DePuy Yun Li Andrew Balshem Al Benson Caroline B Burnett Sandra Corbett John Marshall Elyse Slater Daniel P Sulmasy David Van Echo Neal J Meropol Kevin A Schulman 《Medical decision making》2004,24(6):614-624
OBJECTIVE: The authors sought to empirically test whether relative health stock, a measure of patients' sense of loss in their health due to illness, influences the treatment decisions of patients facing life-threatening conditions. Specifically, they estimated the effect of relative health stock on advanced cancer patients' decisions to participate in phase I clinical trials. METHOD: A multicenter study was conducted to survey 328 advanced cancer patients who were offered the opportunity to participate in phase I trials. The authors asked patients to estimate the probabilities of therapeutic benefits and toxicity, their relative health stock, risk preference, and the importance of quality of life. RESULTS: Controlling for health-related quality of life, an increase in relative health stock by 10 percentage points reduced the odds of choosing to participate in a phase I trial by 16% (odds ratio = 0.84, 95% confidence interval = 0.72, 0.97). CONCLUSION: Relative health stock affects advanced cancer patients' treatment decisions. 相似文献
44.
Toxicity and mAChRs binding activity of Cassiopea xamachana venom from Puerto Rican coasts. 总被引:1,自引:0,他引:1
A separation of toxic components from the upside down jellyfish Cassiopea xamachana (Cx) was carried out to study their cytotoxic effects and examine whether these effects are combined with a binding activity to cell membrane receptors. Nematocysts containing toxins were isolated from the autolysed tentacles, ruptured by sonication, and the crude venom (CxTX) was separated from the pellets by ultracentrifugation. For identifying its bioactive components, CxTX was fractionated by gel filtration chromatography into six fractions (named fraction I-VI). The toxicity of CxTX and fractions was tested on mice; however, the hemolytic activity was tested on saline washed human erythrocytes. The LD50 of CxTX was 0.75 microg/g of mouse body and for fraction III, IV and VI were 0.28, 0.25 and 0.12 microg/g, respectively. Fractions I, II and V were not lethal at doses equivalent to LD50 1 microg/g. The hemolytic and phospholipase A2 (PLA2) activities of most fractions were well correlated with their mice toxicity. However, fraction VI, which contains the low molecular mass protein components (< or =10 kDa), has shown no PLA2 activity but highest toxicity to mice, highest hemolytic activity, and bound significantly to the acetylcholine muscarinic receptors (mAChRs) isolated from rat brain. The results suggested that fraction VI contains proteinaceous components contributing to most of cytolysis as well as membrane binding events. Meanwhile, fraction IV has shown high PLA2 that may contribute to the venom lethality and paralytic effects. 相似文献
45.
46.
Daniel R. Burnett Lauren M. Huyett Howard C. Zisser Francis J. Doyle III Brett D. Mensh 《Diabetes》2014,63(7):2498-2505
The paramount goal in the treatment of type 1 diabetes is the maintenance of normoglycemia. Continuous glucose monitoring (CGM) technologies enable frequent sensing of glucose to inform exogenous insulin delivery timing and dosages. The most commonly available CGMs are limited by the physiology of the subcutaneous space in which they reside. The very same advantages of this minimally invasive approach are disadvantages with respect to speed. Because subcutaneous blood flow is sensitive to local fluctuations (e.g., temperature, mechanical pressure), subcutaneous sensing can be slow and variable. We propose the use of a more central, physiologically stable body space for CGM: the intraperitoneal space. We compared the temporal response characteristics of simultaneously placed subcutaneous and intraperitoneal sensors during intravenous glucose tolerance tests in eight swine. Using compartmental modeling based on simultaneous intravenous sensing, blood draws, and intraarterial sensing, we found that intraperitoneal kinetics were more than twice as fast as subcutaneous kinetics (mean time constant of 5.6 min for intraperitoneal vs. 12.4 min for subcutaneous). Combined with the known faster kinetics of intraperitoneal insulin delivery over subcutaneous delivery, our findings suggest that artificial pancreas technologies may be optimized by sensing glucose and delivering insulin in the intraperitoneal space. 相似文献
47.
48.
49.
Aims: The purpose of this pilot study was to determine the feasibility and usability of daily retrospective assessments of alcohol use using handheld computers and to explore their comparability to Timeline Followback (TLFB) assessments.Methods: College student participants received a Handheld Assessment Tool (HAT) at enrolment, which surveyed alcohol consumption and contextual factors for the previous day. After 1 week of daily monitoring, participants completed a paper‐and‐pencil TLFB assessment and HAT usability scale.Results: Of the 1,800 matched data points on the HAT and TLFB, the overall level of agreement was very good (kappa = 0.80, p<0.001). The mean difference between the number of drinks per drinking days recorded using both methods was 0.19 (SD = 0.56). Participants completed HAT surveys on 87 out of 91 total possible survey days (95.6%). The HAT recorded 34 drinking days and the TLFB recorded 37 out the 91 possible days; the HAT was reported to be highly usable by all participants.Conclusion: Overall, the HAT was found to be usable and feasible and produced high adherence. Further research should validate this alcohol assessment approach and apply it to representative populations. 相似文献
50.
Edith A. Nutescu Allison Burnett John Fanikos Sarah Spinler Ann Wittkowsky 《Journal of thrombosis and thrombolysis》2016,41(1):15-31
Anticoagulant drugs are the foundation of therapy for patients with VTE. While effective therapeutic agents, anticoagulants can also result in hemorrhage and other side effects. Thus, anticoagulant therapy selection should be guided by the risks, benefits and pharmacologic characteristics of each agent for each patient. Safe use of anticoagulants requires not only an in-depth knowledge of their pharmacologic properties but also a comprehensive approach to patient management and education. This paper will summarize the key pharmacologic properties of the anticoagulant agents used in the treatment of patients with VTE. 相似文献